🇨🇦 Fondaparinux background and low dose heparin in Canada

Fondaparinux background and low dose heparin (Fondaparinux background and low dose heparin) regulatory status in Canada.

Marketing authorisation

Fondaparinux background and low dose heparin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fondaparinux background and low dose heparin approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Fondaparinux background and low dose heparin in Canada?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.